Celgene CEO on paying for cancer care

8:34 AM ET Mon, 5 June 2017

With the focus on drug prices as sharp as ever—President Trump in January accused the pharmaceutical industry of "getting away with murder" on its prices—Celgene CEO Mark Alles says the U.S. must rethink the way patients pay for cancer care.